PharmaCyte Biotech Inc (PMCB)

[Edward]

Iroquois does not what to do with PMCB.

They can't sell it, the product is worthless.

The only thing they have is the appox. 15 % interest in in SG Austria which they are carrying @ 1.6 million on the balance sheet.

Willing to bet it is worth much less since they would show using the equity method (actual vale) rather than cost.

Also they have intangibles which they carry @ 3.5 million, but are also actually worthless since an intangible asset is an asset that is not physical in nature. Goodwill, brand recognition and intellectual property, such as patents, trademarks, and copyrights, are all intangible assets. I


All they are doing is collecting directors fees, and will continue to do so for quite a while.